Cybin (HELP) Shares Outstanding (Weighted Average) (2020 - 2025)

Cybin (HELP) reported Shares Outstanding (Weighted Average) of $16.2 million for Q2 2025, up 10.55% on a YoY basis from $14.6 million in Q2 2024, and up 7.35% quarter-over-quarter from $15.1 million in Q1 2025.

Cybin (HELP) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends

Cybin has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $16.2 million in Q2 2025.

  • For the quarter ending Q2 2025, Shares Outstanding (Weighted Average) rose 10.55% year-over-year to $16.2 million; the trailing twelve-month figure through Jun 2025 stood at $16.2 million (up 10.55% YoY), and the FY2025 full-year result was $15.5 million, down 95.28% from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2025 stood at $16.2 million, up from $15.1 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $4.6 billion in Q3 2023, with the low at $15.74 in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $367.4 million across 5 years, with a median of $124.4 million in 2021.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 4820.87% in 2024 against a maximum downside of 99.68% in 2024.
  • Cybin's Shares Outstanding (Weighted Average) stood at $110.7 million in 2021, then gained by 25.72% to $139.2 million in 2022, then sank by 95.36% to $6.4 million in 2023, then soared by 4820.87% to $317.4 million in 2024, then sank by 94.91% to $16.2 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $16.2 million (Q2 2025), $15.1 million (Q1 2025), and $317.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Cybin 75.42 Mn 75.42 Mn - 16.17 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 16.17 Mn
Mar 31, 2025 15.06 Mn
Dec 31, 2024 317.40 Mn
Sep 30, 2024 14.66 Mn
Jun 30, 2024 14.62 Mn
Mar 31, 2024 329.41 Mn
Dec 31, 2023 6.45 Mn
Sep 30, 2023 4.60 Bn
Jun 30, 2023 153.47 Mn
Feb 28, 2023 51.91
Dec 31, 2022 139.15 Mn
Sep 30, 2022 138.66 Mn
May 31, 2022 15.74
Dec 31, 2021 110.68 Mn
Sep 30, 2021 131.70 Mn
Jun 30, 2021 128.30 Mn
Mar 31, 2021 124.40 Mn
Sep 30, 2020 51.89 Mn
Jun 30, 2020 43.78 Mn